BIO International Convention Celebrating its 25th Anniversary in Boston

Just as the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting ended yesterday in Chicago, hundreds miles away from Chicago the Biotechnology Innovation Organization (BIO) is having the 2018 BIO International Convention and celebrating its 25th anniversary at the Boston Convention & Exhibition Center, Boston.

By Joanne Shih

The BIO International Convention is one of the most predominant event for the biotechnology industry in the world. 25 years ago, the BIO kicked of its first International Convention in 1993 and attracted approximately 1,400 attendees in biotechnology industry including public and private sectors, governors, and academics. This year the organization sets a theme of “Make History” for the 2018 convention, offering industrial leaders, scientists, and policymakers a gathering occasion to interact and to inspire innovative solutions for life science, healthcare, agricultural, and environmental biotechnology.

Through out the four-day event, over 18 education tracks covering a wide range of topics from genome editing, personalized medicine, oncology, next generation biotherapeutics, and food and agriculture keep the BIO attendees updated with current trends in each field. Moreover, there are 9 Fireside Chats featuring leaders from pharmaceutical giants, academic organizations, and regulators including U.S. Food and Drug Administration allowing the public to have conversation with managing and supervisory level regarding financing, regulatory issues and business operation in biotechnology.

More than 1,100 biotechnology companies, academic institutions, and related organizations participate in this year’s event. To facilitate partnerships in the biotechnology industry, BIO also hosts One-on-One Partnering during the convention. Key players from top-notch companies in the biotechnology and pharmaceutical industries, including Merck, Pfizer, Thermo Fisher Scientific, Takeda, and Johnson & Johnson, participate in the program, which allows growing businesses and start-ups from around the world to have opportunities to meet with industrial leaders and to further develop collaboration. In addition, BIO also hosts Start-up Stadium for young business to increase their visibility to venture capitals and philanthropy groups and to attract fundings. Around 50 start-up companies present in the Start-up Stadium to pitch themselves, and will be judged by an international board.

Reference
http://convention.bio.org/home.aspx

Author

GeneOnline